Xu, Dongsheng
Zhang, You
Huang, Wei
Pan, Xinbing
An, Shuxian
Wang, Cheng
Huang, Gang
Liu, Jianjun
Wei, Weijun https://orcid.org/0000-0003-3190-2480
Funding for this research was provided by:
National Key Research and Development Program of China (2020YFA0909000)
National Natural Science Foundation of China (82372014)
Shen Kang-United Imaging Joint Research and Development Plan (SKLY2022CRT301)
Article History
Received: 29 June 2024
Accepted: 28 August 2024
First Online: 9 September 2024
Declarations
:
: The Institutional Committee for the Care and Use of Animals (Renji Hospital, Shanghai Jiao Tong University School of Medicine) approved all animal imaging studies. The current study did not include patient information.
: W. Wei is a consultant of Alpha Nuclide (Ningbo) Medical Technology Co., Ltd. W. Wei, D. Xu, and J. Liu are co-inventors of pending patents describing the imaging technologies reported in the manuscript. W. Wei is on the editorial board of the European Journal of Nuclear Medicine and Molecular Imaging.